Polycystic Ovarian Syndrome: An Evidence-based Approach to Evaluation and Management of Diabetes and Cardiovascular Risks for Today??s Clinician
The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
This review systematically addresses the evidence confirming polycystic ovary syndrome (PCOS) as a cardiovascular health threat. Literature in this area is void of long-term prospective studies to adequately evaluate outcome, but there is important evidence using surrogate markers for future development of and presence of cardiovascular disease and diabetes in women with PCOS. In addition, this article reviews the evidence regarding evaluation and management of cardiovascular risk factors in the population of women with PCOS. We seek to review the literature to determine when or if recommendations for management of women with PCOS should deviate from guidelines for the population at large.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ridker, P. M., Buring, J. E., Cook, N. R., & Rifai, N. (2003) · Circulation · doi:10.1161/01.cir.0000055014.62083.05 · Cited by 2,292
Profound Peripheral Insulin Resistance, Independent of Obesity, in Polycystic Ovary Syndrome
Dunaif, A., Segal, K. R., Futterweit, W., & Dobrjansky, A. (1989) · Diabetes · doi:10.2337/diab.38.9.1165 · Cited by 1,967
Legro, R. S. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.1.165 · Cited by 1,743 · cited 2×
“8% of nonobese PCOS patients had impaired glucose tolerance.(33) Other investigators have corroborated these estimates.”
MethodResultPrevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.
Ehrmann, D. A., Barnes, R. B., Rosenfield, R. L., Cavaghan, M. K., & Imperial, J. (1999) · Diabetes Care · doi:10.2337/diacare.22.1.141 · Cited by 1,257
Wild, S., Pierpoint, T., McKeigue, P., & Jacobs, H. (2000) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2000.01000.x · Cited by 970 · cited 1×
“Some researchers have noted no higher morbidity or mortality rates from circulatory diseases in women with PCOS.(2,3) To mount a cohort study of women with PCOS is a difficult task.”
BackgroundLow grade chronic inflammation in women with polycystic ovarian syndrome
Kelly, C. C. J., Lyall, H., Petrie, J. R., Gould, G. W., Connell, J. M. C., & Sattar, N. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.6.7580 · Cited by 640
Moran, L. J., Noakes, M., Clifton, P. M., Tomlinson, L., & Norman, R. J. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020815 · Cited by 530
Jakicic, J. M., Marcus, B. H., Gallagher, K. I., Napolitano, M., & Lang, W. (2003) · JAMA · doi:10.1001/jama.290.10.1323 · Cited by 519
Mortality of Women with Polycystic Ovary Syndrome at Long-term Follow-up
Pierpoint, T., McKeigue, P. M., Isaacs, A. J., Wild, S. H., & Jacobs, H. S. (1998) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(98)00035-3 · Cited by 504 · cited 1×
“Some researchers have noted no higher morbidity or mortality rates from circulatory diseases in women with PCOS.(2,3) To mount a cohort study of women with PCOS is a difficult task.”
BackgroundThe natural history of impaired glucose tolerance in the Pima Indians
Saad, M. F., Knowler, W. C., Pettitt, D. J., Nelson, R. G., Mott, D. M., & Bennett, P. H. (1988) · New England Journal of Medicine · doi:10.1056/nejm198812083192302 · Cited by 413
Research works printed but not linked: 47
- Dokras, 2005, Obstet Gynecol, 106, 131, 10.1097/01.AOG.0000167408.30893.6b · DOI · Paper page
- Lo, 2006, J Clin Endocrinol Metab, 91, 1357, 10.1210/jc.2005-2430 · DOI · Paper page
- Wild, 2002, Am J Obstet Gynecol, 186, 35, 10.1067/mob.2002.119180 · DOI
- Orio, 2004, J Clin Endocrinol Metab, 89, 3696, 10.1210/jc.2003-032049 · DOI · Paper page
- Talbott, 2000, Arterioscler Thromb Vasc Biol, 20, 2414, 10.1161/01.ATV.20.11.2414 · DOI · Paper page
- Christian, 2003, J Clin Endocrinol Metab, 88, 2562, 10.1210/jc.2003-030334 · DOI · Paper page
- Schachter, 2003, Hum Reprod, 18, 721, 10.1093/humrep/deg190 · DOI · Paper page
- Orio, 2004, J Clin Endocrinol Metab, 89, 4588, 10.1210/jc.2003-031867 · DOI · Paper page
- Talbott, 2004, J Clin Endocrinol Metab, 89, 6061, 10.1210/jc.2003-032110 · DOI · Paper page
- Carmina, 2006, Am J Med, 119, 356, 10.1016/j.amjmed.2005.10.059 · DOI · Paper page
- Paradisi, 2001, Circulation, 103, 1410, 10.1161/01.CIR.103.10.1410 · DOI · Paper page
- Sangiorgi, 1998, J Am Coll Cardiol, 31, 126, 10.1016/S0735-1097(97)00443-9 · DOI · Paper page
- Arad, 1996, Circulation, 93, 1951, 10.1161/01.CIR.93.11.1951 · DOI · Paper page
- Detrano, 1997, Am J Med, 102, 344, 10.1016/S0002-9343(97)00085-5 · DOI
- Valabhji, 2002, Curr Opin Lipidol, 13, 409, 10.1097/00041433-200208000-00008 · DOI
- Talbott, 2004, J Clin Endocrinol Metab, 89, 5454, 10.1210/jc.2003-032237 · DOI · Paper page
- Boulman, 2004, J Clin Endocrinol Metab, 89, 2160, 10.1210/jc.2003-031096 · DOI · Paper page
- Pearson, 2003, Circulation, 107, 499, 10.1161/01.CIR.0000052939.59093.45 · DOI · Paper page
- Schachter, 2003, Hum Reprod, 18, 721, 10.1093/humrep/deg190 · DOI · Paper page
- Kilic-Okman, 2004, Endocr J, 51, 505, 10.1507/endocrj.51.505 · DOI
- Loverro, 2002, Gynecol Obstet Invest, 53, 157, 10.1159/000058367 · DOI · Paper page
- Carmina, 2006, Am J Med, 119, 356, 10.1016/j.amjmed.2005.10.059 · DOI · Paper page
- Orio, 2005, J Clin Endocrinol Metab, 90, 2, 10.1210/jc.2004-0628 · DOI · Paper page
- Escobar-Morreale, 2004, J Clin Endocrinol Metab, 89, 806, 10.1210/jc.2003-031365 · DOI · Paper page
- Lewandowski, 2006, J Clin Endocrinol Metab, 91, 1173, 10.1210/jc.2005-0648 · DOI · Paper page
- Fogel, 2001, J Clin Endocrinol Metab, 86, 1175
- Legro, 1999, J Clin Endocrinol Metab, 84, 165
- Harris, 1996, Diabet Med, 13, S9
- Boudreaux, 2006, Curr Diab Rep, 6, 77, 10.1007/s11892-006-0056-1 · DOI
- Legro, 2004, Obstet Gynecol Surv, 59, 141, 10.1097/01.OGX.0000109523.25076.E2 · DOI · Paper page
- Pearson, 2002, Circulation, 106, 388, 10.1161/01.CIR.0000020190.45892.75 · DOI · Paper page
- Fox, 1999, Gynecol Endocrinol, 13, 390, 10.3109/09513599909167585 · DOI
- Goldfine, 2006, J Am Coll Cardiol, 47, 2456, 10.1016/j.jacc.2006.02.045 · DOI
- Wild, 2005, J Clin Endocrinol Metab, 90, 4112, 10.1210/jc.2004-2243 · DOI · Paper page
- Stamets, 2004, Fertil Steril, 81, 630, 10.1016/j.fertnstert.2003.08.023 · DOI · Paper page
- Randeva, 2002, J Clin Endocrinol Metab, 87, 4496, 10.1210/jc.2001-012056 · DOI · Paper page
- Carmina, 2006, Minerva Ginecol, 58, 109
- Orio, 2005, J Clin Endocrinol Metab, 90, 6072, 10.1210/jc.2005-0965 · DOI · Paper page
- Morin-Papunen, 2003, J Clin Endocrinol Metab, 88, 4649, 10.1210/jc.2002-021688 · DOI · Paper page
- Legro, 2003, J Clin Endocrinol Metab, 88, 5137, 10.1210/jc.2003-030044 · DOI · Paper page
- Paradisi, 2003, J Clin Endocrinol Metab, 88, 576, 10.1210/jc.2002-020386 · DOI
- Korytkowski, 1995, J Clin Endocrinol Metab, 80, 3327
- Nader, 1997, J Clin Endocrinol Metab, 82, 3074
- Morin-Papunen, 2000, J Clin Endocrinol Metab, 85, 3161
- Elter, 2002, Hum Reprod, 17, 1729, 10.1093/humrep/17.7.1729 · DOI · Paper page
- Morin-Papunen, 2003, J Clin Endocrinol Metab, 88, 148, 10.1210/jc.2002-020997 · DOI · Paper page
- Amanti-Kandarakis, 2003, J Clin Endocrinol Metab, 88, 1927, 10.1210/jc.2002-021528 · DOI · Paper page
Cited by
Exercise as medicine - evidence for prescribing exercise as therapy in 26 different chronic diseases
Pedersen, B. K., & Saltin, B. (2015) · Scandinavian Journal of Medicine & Science in Sports · doi:10.1111/sms.12581 · Cited by 3,514
Xia, Y., Wang, Y., Cui, M., & Su, D. (2021) · Annals of Palliative Medicine · doi:10.21037/apm-21-1050 · Cited by 23
Yuan, J., Wen, X., & Jia, M. (2021) · Annals of Palliative Medicine · doi:10.21037/apm-21-2018 · Cited by 22
“Effect of n-3 PUFA supplementation on hormones PCOS has clinical heterogeneity, which is based on the influence of genetic and environmental factors (31).”
BackgroundTokmak, A., Timur, H., Aksoy, R. T., Çınar, M., & Yılmaz, N. (2015) · Journal of Turkish Society of Obstetric and Gynecology · doi:10.4274/tjod.21549 · Cited by 15
Aghahosseini, M., Aleyaseen, A., Safdarian, L., Moddaress-Hashemi, S., Mofid, B., & Kashani, L. (2010) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-010-1579-x · Cited by 12
Metadata
- Authors
- LORENZ, L. B., & WILD, R. A.
- Venue
- Clinical Obstetrics and Gynecology
- Published
- 2007-03
- Volume
- 50
- Issue
- 1
- Pages
- 226-243
- ISSN
- 0009-9201 (ISSN-L)
- OpenAlex
- W2040617246
- Cited by
- 43
- References
- 15
- FWCI
- 3.89
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Polycystic Ovarian Syndrome: An Evidence-based Approach to Evaluation and Management of Diabetes and Cardiovascular Risks for Today??s Clinician. https://app.cochat.ai/papers/10.1097/grf.0b013e31802f5197
- The paper
- LORENZ, L. B., & WILD, R. A. (2007). Polycystic Ovarian Syndrome: An Evidence-based Approach to Evaluation and Management of Diabetes and Cardiovascular Risks for Today??s Clinician. Clinical Obstetrics and Gynecology. https://doi.org/10.1097/grf.0b013e31802f5197
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.